| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 732.90M | 588.50M | 745.50M | 795.10M | 755.90M | 761.00M |
| Gross Profit | 300.00M | 295.50M | 627.10M | 663.90M | 625.10M | 336.70M |
| EBITDA | 212.70M | 234.20M | 231.20M | 286.10M | 224.60M | 214.80M |
| Net Income | 158.00M | 163.90M | 163.80M | 205.30M | 154.40M | 155.40M |
Balance Sheet | ||||||
| Total Assets | 13.64B | 11.12B | 10.81B | 11.68B | 9.90B | 7.65B |
| Cash, Cash Equivalents and Short-Term Investments | 351.40M | 378.50M | 10.34B | 11.18B | 9.40B | 7.22B |
| Total Debt | 153.40M | 94.70M | 102.70M | 109.40M | 110.40M | 101.60M |
| Total Liabilities | 13.25B | 10.75B | 10.46B | 11.34B | 9.65B | 7.50B |
| Stockholders Equity | 390.80M | 367.40M | 349.80M | 341.50M | 253.20M | 150.70M |
Cash Flow | ||||||
| Free Cash Flow | 210.20M | 169.30M | 73.40M | 653.20M | 440.00M | 800.20M |
| Operating Cash Flow | 214.40M | 171.80M | 74.60M | 654.60M | 459.40M | 813.60M |
| Investing Cash Flow | -6.80M | -4.40M | 2.40M | -393.10M | -408.70M | -672.00M |
| Financing Cash Flow | -163.90M | -163.80M | -164.30M | -145.70M | -68.90M | -199.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £4.03B | 5.71 | 41.35% | 5.93% | 4.28% | 5.18% | |
77 Outperform | £3.87B | 6.07 | 7.96% | 7.21% | -1.72% | 63.64% | |
76 Outperform | £8.99B | 4.03 | 12.35% | 5.37% | 12.45% | 28.89% | |
74 Outperform | £2.48B | 8.36 | 8.35% | 3.40% | 71.85% | ― | |
70 Outperform | £2.07B | 6.49 | 8.33% | 4.91% | 2.02% | 69.06% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
52 Neutral | £7.23B | 28.90 | 9.49% | 7.09% | 52.52% | ― |